remaining hospitalization. The stool samples were analyzed by standard procedures for 26 enterics, followed by speciation with the ATB ID32E test (bioMérieux) and susceptibility 27 testing by disk-diffusion according to the CLSI [6] , including imipenem, meropenem, and 28 ertapenem. On the 27 th of June, the sample was finally free of K. pneumoniae, and this was 29 confirmed in several subsequent analyses. On the 17 th of July, the patient, disqualified for 30 heart transplantation, was discharged from center H2 without symptoms of infection. 31
Analyzed by Etest (AB Biodisk, Solna, Sweden), the isolates showed multi-resistance, 32 including reduced susceptibility to carbapenems (Table 1 ). In the spectrophotometric assay 33
[17] bacterial sonicates hydrolyzed imipenem in the EDTA-independent manner. Isoelectric 34 focusing [1] visualized β-lactamases with pIs of 7.6 (probably the SHV-like chromosomal 35 enzymes) and three others, with pIs of 8.2, ~6.8 and 5.4. Since the pI ~6.8 specifies the KPC-36 2/-3 β-lactamases, a PCR [13] and sequencing were performed, which identified the bla KPC-2 37 genes [19] . PCR mapping revealed that they resided in one of the Tn4401 transposon variants, 38
Tn4401a [12] . Mating was performed with Escherichia coli A15 Rif R [1] ; transconjugants 39 were selected with 100µg/ml rifampin and 0.5µg/ml imipenem or 2µg/ml ceftazidime. Only 40 isolate 2641/08 gave a transconjugant on the imipenem plate with KPC-2 and the pI 5.4 41 enzyme, identified by PCR and sequencing [9] as TEM-1. Contrarily, all isolates yielded 42 transconjugants on ceftazidime plates which had only the 8.2 enzymes, found by PCR and 43 sequencing [9] to be extended-spectrum β-lactamase (ESBL) SHV-12. Plasmid DNA of the 44 isolates, purified with the QIAGEN Plasmid Midi Kit (QIAGEN, Hilden, Germany), was used 45 for electroporation of E. coli DH5α, analyzed then on 0.5µg/ml imipenem plates. 46
Transformants with KPC-2 and TEM-1 were obtained for all isolates. PstI fingerprinting [9] 47 showed three plasmid molecules in each isolate, two of which segregated to SHV-12-48 producing transconjugants and KPC-2/TEM-1-producing transformants, respectively (Figure 49 
